Related Experiment Video
Updated: Jun 15, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Cardiogenic Shock Teams: Past, Present, and Future Directions
Vanessa Blumer1, Thomas C Hanff2, Ann Gage3
1Inova Schar Heart and Vascular, Falls Church, VA (V.B.).
Insights
Structured cardiogenic shock (CS) teams improve survival rates and reduce complications. Standardizing protocols, prompt recognition, and early interventions are crucial for better patient outcomes in CS management.
Area of Science:
- Cardiovascular Medicine
- Critical Care Medicine
Background:
- Cardiogenic shock (CS) presents significant morbidity and mortality challenges.
- Historically, patient outcomes in CS are highly variable, depending on intervention timing and center expertise.
- Emerging evidence supports structured, team-based approaches for improving CS survival rates.
Purpose of the Study:
- To review the evolution, current implementation, and future directions of cardiogenic shock (CS) teams.
- To emphasize the critical role of CS teams in enhancing patient outcomes.
- To advocate for standardized protocols and integrated management strategies.
Main Methods:
- Review of existing literature on cardiogenic shock team models.
- Analysis of challenges in team composition and resource distribution.
- Discussion of standardized protocols, hemodynamic monitoring, and mechanical circulatory support.
Main Results:
- Structured team-based approaches significantly improve survival rates and diminish CS complications.
- Standardized protocols are essential for uniform care delivery across institutions.
- Early recognition and management, including invasive monitoring and mechanical support, are vital.
Conclusions:
- CS teams are crucial for improving patient outcomes and survival rates.
- Standardization, innovation, and data sharing through national registries are imperative.
- Extending CS team models into regional networks can broaden their impact via education and telemedicine.
Abstract:
Cardiogenic shock (CS) remains a significant challenge in cardiovascular medicine, characterized by substantial morbidity and mortality. Historically, patient outcomes in CS have been varied, highly dependent on the timeliness of interventions and the expertise available at treating centers. Emerging evidence indicates that structured, team-based approaches significantly improve survival rates and diminish complications linked to CS. However, several challenges for implementing a team-based approach persist, including optimizing team composition and resource distribution. This article delves into the evolution, current implementations, and future directions of CS teams, emphasizing their crucial role in enhancing patient outcomes. We advocate for the adoption of standardized protocols to ensure uniformity of care across institutions, highlighting the critical need for prompt recognition and management strategies that integrate invasive hemodynamic monitoring and early mechanical circulatory support. Looking ahead, we propose the extension of CS team models into regional networks, broadening their impact through education, telemedicine and collaborative protocols. We also emphasize the importance of continuous research and data sharing via national registries to refine CS team strategies and substantiate their effects on patient outcomes. Ultimately, this review highlights the imperative for ongoing innovation and standardization in CS team operations to improve care delivery and enhance survival rates in CS scenarios.
Related Concept Videos
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Acute Coronary Syndrome IV: Interprofessional Care
Cardiopulmonary Resuscitation III: AED Use
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

